Literature DB >> 9035365

"Hairpin" and "hammerhead" ribozymes directed towards the mumps virus nucleocapsid RNA: specific cleavage of a small synthetic RNA substrate and full-length mRNA.

J Albuquerque-Silva1, M J De Vos, A Bollen, S Houard.   

Abstract

In an attempt to develop efficient antiviral agents against Mumps virus, we designed ribozymes targeting the nucleocapsid (NP) mRNA. Transacting catalytic RNAs of the hammerhead and hairpin types were synthesized; they contained specific motifs, shared similar flanking regions and were directed against a 5'GUC3' target immediately downstream to the initiation codon of NP mRNA. Both ribozymes were first assayed on a synthetic 16 bases target RNA and found to catalytically and efficiently cleave the substrate in a sequence specific way. No cleavage, however, occurred when mutated forms of the ribozymes were used. In addition, both ribozyme types, when tested on the full length NP mRNA, were also able to cleave the substrate although turnover could not be demonstrated. As a rule, the hammerhead ribozyme proved more efficient than its hairpin counterpart, as well on the synthetic RNA substrate as on the full length NP mRNA target.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9035365     DOI: 10.1007/bf00366981

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

1.  A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.

Authors:  P Hendry; M J McCall; F S Santiago; P A Jennings
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Extended target-site specificity for a hammerhead ribozyme.

Authors:  R Perriman; A Delves; W L Gerlach
Journal:  Gene       Date:  1992-04-15       Impact factor: 3.688

3.  Substrate sequence effects on "hammerhead" RNA catalytic efficiency.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Different target-site specificities of the hairpin ribozyme in cis and trans cleavages.

Authors:  K Fujitani; N Sasaki-Tozawa; Y Kikuchi
Journal:  FEBS Lett       Date:  1993-09-27       Impact factor: 4.124

Review 5.  Antisense treatment of viral infection.

Authors:  J L Whitton
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

Review 6.  Ribozymes: a distinct class of metalloenzymes.

Authors:  A M Pyle
Journal:  Science       Date:  1993-08-06       Impact factor: 47.728

7.  An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield.

Authors:  Z Xing; J L Whitton
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.

Authors:  J O Ojwang; A Hampel; D J Looney; F Wong-Staal; J Rappaport
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1.

Authors:  E L Bertrand; J J Rossi
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  Cytoplasmic delivery of ribozymes leads to efficient reduction in alpha-lactalbumin mRNA levels in C127I mouse cells.

Authors:  P J L'Huillier; S R Davis; A R Bellamy
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  1 in total

1.  Tailing cDNAs with terminal deoxynucleotidyl transferase in RT-PCR assays to identify ribozyme cleavage products.

Authors:  J Albuquerque-Silva; S Houard; A Bollen
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.